Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Neurobiol Dis. 2017 Jul 6;106:181–190. doi: 10.1016/j.nbd.2017.07.006

Table 1.

Comparison of Family Members with GPR37L1-K349N Variant

VI: 1* VI:4* VI:5* VI:6 VI:7 VI:8 VI:9 VI:10 VI:11 VI:12
Age of Clinical Presentation (Years) 14 14 13 12 10 n/a 13 n/a 11 12
Age of Death (Years) 19 19 18 18 16 n/a 20 n/a n/a n/a
Current Age (Years) n/a n/a n/a n/a n/a 24 n/a 18 15 12
Sex male female female female female female female female male male
K349N mutation Not tested Not tested Not tested Not tested Not tested Heterozygous c.1047G>T (Lys349Asp) WT c.1047G>T (Lys349Asp) c.1047G>T (Lys349Asp)
Recurrent Headaches + + + + + + + +
Progressive Myoclonic Epilepsy + + + + + +
Seizures + + + + + +
Visual Hallucinations + + + + + + +
Cognitive Decline + + + + + +
Brain Imaging mild prominence of the subarachnoid spaces; otherwise unremarkable
EEG intermittent superimposed posterior 5–6 Hz background activity, recurrent generalized high voltage 4–6 Hz spike, polyspike and slow wave discharges with occasional abortive generalized high voltage spike and slow wave discharges generalized spike and wave complexes; occipital sharp waves
*

Denotes individuals for whom clinical information was relayed by family members